Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is that enough?
Fierce Pharma
Fri, 10/5/18 - 08:51 pm
Tags:
Boehringer Ingelheim, Eli Lilly, Tradjenta, diabetes
Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results
Endpoints
Thu, 10/4/18 - 11:58 am
Tags:
Eli Lilly, diabetes, Novo Nordisk, Ozempic, LY3298176, Trulicity
Eli Lilly's diabetes treatment meets main goal in two late-stage studies
Reuters
Tue, 10/2/18 - 10:54 pm
Tags:
Eli Lilly, Ultra Rapid Lispro, Humalog, diabetes, type 1 diabetes, type 2 diabetes
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Marketwatch
Fri, 09/28/18 - 12:32 pm
Tags:
migraines, Eli Lilly, Emgality, Teva Pharmaceutical, Ajovy, Amgen, Novartis, Aimovig
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of its ED blockbuster
Fierce Pharma
Fri, 09/28/18 - 11:58 am
Tags:
Eli Lilly, Cialis, generics, Teva Pharmaceutical, erectile dysfunction
Lilly’s Emgality nabs third-to-market migraine nod, but aims to be 'treatment of choice' in CGRP
Fierce Pharma
Thu, 09/27/18 - 11:25 pm
Tags:
Eli Lilly, Emgality, migraines
Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront
BioSpace
Thu, 09/27/18 - 11:53 am
Tags:
Eli Lilly, Chugai, OWL833, type 2 diabetes
Elanco’s $1.7 billion IPO looks too pricey, and here’s why
Marketwatch
Thu, 09/20/18 - 09:49 am
Tags:
Elanco, Eli Lilly, IPOs, animal health, spinoffs
Eli Lilly got Indianapolis tax break despite pending appeals
AP
Mon, 09/10/18 - 12:14 am
Tags:
Eli Lilly, taxes, Indianapolis
Eli Lilly's New PET Scan Offers Another Tool for Studying Alzheimer's
BioSpace
Fri, 09/7/18 - 11:02 am
Tags:
Eli Lilly, Avid Radiopharmaceuticals, PET scans, tau, Alzheimer's disease, devices
Tanezumab's Phase 3 Results: A Promising Sign For Non-Opioid Pain Treatments
Forbes
Thu, 09/6/18 - 09:44 am
Tags:
opioids, tanezumab, opioid crisis, pain management, clinical trials, Pfizer, Eli Lilly
Boost for "made in China" medicine as Chi-Med wins key approval
Yahoo/Reuters
Wed, 09/5/18 - 09:08 am
Tags:
China, Chi-Med, Eli Lilly, fruquintinib, colorectal cancer
Trulicity’s turn to show a cardiovascular benefit
EP Vantage
Tue, 09/4/18 - 05:04 pm
Tags:
Trulicity, Eli Lilly
Adocia and Lilly’s legal tussle intensifies as diabetes deal goes wrong
Pharmaforum
Mon, 09/3/18 - 12:11 pm
Tags:
Eli Lilly, Adocia, insulin, diabetes
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Sat, 09/1/18 - 03:38 pm
Tags:
biotech, FDA, Roche, Tecentriq, GSK, mepolizumab, Teva Pharmaceutical, fremanezumab, Adamis Pharmaceuticals, Symjepi, Insmed, ALIS, Antares, XYOSTED, Eli Lilly, galcanezumab, Pfizer, dacomitinib
Did HHS chief Alex Azar work with ex-employer Lilly on drug rebate plans? A watchdog wants to know
Fierce Pharma
Fri, 08/31/18 - 11:46 pm
Tags:
drug rebates, Alex Azar, HHS, Eli Lilly
Conor Daly's Lilly sponsorship decals removed because of father's use of racial slur in 1980s
Indianapolis Star, IN
Mon, 08/27/18 - 11:35 am
Tags:
Eli Lilly, celebrity endorsements
Boehringer, Lilly diabetes drug Tradjenta succeeds in cardiovascular outcome trial
Pharmaceutical Business Review
Sun, 08/26/18 - 12:00 pm
Tags:
Boehringer Ingelheim, Eli Lilly, clinical trials, diabetes, Tradjenta
Court tosses kickbacks case against Eli Lilly but allows plaintiffs another chance
Fierce Pharma
Wed, 08/15/18 - 10:27 pm
Tags:
Eli Lilly, whistleblowers, kickbacks, Humalog, Humulin, Forteo
Accelerator Life Science Partners Launch Startup With $31 Million Series A
CP Wire
Mon, 08/13/18 - 11:15 am
Tags:
Eli Lilly, Pfizer Ventures, JNJ Ventures, AbbVie Ventures, Accelerator Life Science Partners, Magnolia Neurosciences Corporation

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.